Challenges: The evaluation of Evans Blue Dye (EBD) by fluorescence measurements of cryosections of individual muscle sections, and its quantification by auto fluorescence is a laborious and time-consuming process. Study design: Both sham and thermal injury techniques were followed. The evaluation of EBD was done to assess the effectiveness of two compounds in the process of muscle regeneration.
Aurigene solution & protocol:
An alternate methodology was developed; which involved evaluation of EBD through dye extraction; resulting in fast delivery. TA muscle from both the hind limbs were dissected and immediately placed in sodium sulphate. Acetone was added and kept aside for overnight to extract the dye. After overnight extraction, centrifugation was done and supernatant was separated. Optical density was measured in duplicate using micro plate reader. Optical density of right leg dye extraction was subtracted from left leg for each animal. Outcome: The reference compound profiled in this model demonstrated dose dependent reduction in muscle injury and regeneration up to 10 mpk and there afterwards saturable effect with maximal efficacy of ~60%. Based on this model, several compounds were profiled in short frame of time to identify the lead molecule currently in clinical development. Corrected OD ( Mean,SE)
Contact Us
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market